Sanoficanada.mediaroom.com

Health Canada accepts nirsevimab regulatory submission for …

Nirsevimab has already been approved by the European Commission and the UK as the first and only broadly protective option against RSV for newborns and infants. TORONTO, Jan. 18, 2023 /CNW/ - Health Canada has accepted a New Drug Submission (NDS) for nirsevimab, the first investigational single-dose long-acting antibody designed for all infants

Actived: 5 days ago

URL: https://sanoficanada.mediaroom.com/2023-01-18-Health-Canada-accepts-nirsevimab-regulatory-submission-for-infant-RSV

DUPIXENT® (dupilumab injection) is now approved in Canada for …

WebDUPIXENT ® is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not an …

Category:  Health Go Health

DUPIXENT® (dupilumab injection) now approved by Health …

Web"For Canadians struggling with severe asthma, the approval of Dupixent offers an exciting new treatment pathway," says Dr. Kenneth Chapman, Professor of …

Category:  Health Go Health

Health Canada approves BEYFORTUS™ (nirsevimab) for the …

WebBEYFORTUS™ is approved by Health Canada for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants …

Category:  Health Go Health

New SARCLISA® (isatuximab for injection) Combination Now …

WebThe approval is based on data from the Phase 3 IKEMA study. 1,2 Multiple myeloma (MM) is the third most common blood cancer in Canada, with an estimated …

Category:  Cancer Go Health

DUPIXENT® (dupilumab injection) now publicly reimbursed in …

Web* DUPIXENT ® is the only biologic medicine approved by Health Canada to treat moderate-to-severe atopic dermatitis. * Public reimbursement under the Ontario …

Category:  Medicine Go Health

Cablivi® (caplacizumab) approved by Health Canada for adults …

WebCablivi ® is the first treatment approved in Canada for aTTP, a life-threatening blood clotting disorder ; It's estimated that up to 20% of patients die from TTP episodes, …

Category:  Health Go Health

DUPIXENT® (dupilumab injection) now approved in Canada for …

Web* This is the seventh indication for Dupixent ® in Canada. TORONTO, April 20, 2023 /CNW/ - Sanofi-aventis Canada Inc. (Sanofi Canada) announced today that …

Category:  Health Go Health

Libtayo® (cemiplimab) approved in Canada for the first-line …

WebThe approval is based on data from the randomized, open-label, multi-center Study 1624 1; MISSISSAUGA, ON, Oct. 29, 2021 /CNW/ - Libtayo ® (cemiplimab) is now …

Category:  Health Go Health

Libtayo® (cemiplimab) in Combination with Chemotherapy now …

WebLibtayo ® is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T-cells. By binding to PD-1, Libtayo ® has been shown to …

Category:  Health Go Health

DUPIXENT® (dupilumab injection) pre-filled pen now available in …

WebDUPIXENT ® is approved by Health Canada for use in moderate-to-severe atopic dermatitis, severe chronic rhinosinusitis with nasal polyposis and severe asthma. …

Category:  Health Go Health

Sanofi to build new manufacturing facility in Toronto to …

WebSanofi announces investment of approximately $925 million (CAD) to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines …

Category:  Health Go Health

Libtayo® (cemiplimab) approved in Canada for locally advanced …

WebThe approval is based on data from the open-label, multi-center, non-randomized Study 1620 1; MISSISSAUGA, ON, Oct. 29, 2021 /CNW/ - Libtayo ® …

Category:  Health Go Health

Press Release: Dupixent® (dupilumab injection) receives …

WebDupixent ® reduced itch and skin lesions compared to placebo in a direct-to-Phase 3 program consisting of two pivotal trials; Authorization represents the second …

Category:  Health Go Health

Sanofi Canada furthers commitment to Canadians living with …

WebLAVAL, QC, June 14, 2022 /CNW Telbec/ - Since the onset of the COVID-19 pandemic, diabetes care has been significantly impacted by the reduction in access to healthcare …

Category:  Health Go Health

Sanofi Canada and Diabetes Care Community announce a …

WebTORONTO, May 1, 2023 /CNW/ - sanofi-aventis Canada Inc. (Sanofi Canada) and Diabetes Care Community Inc. (DCC) are pleased to announce a collaboration to …

Category:  Health Go Health

Nexviazyme™ (avalglucosidase alfa for injection) is now approved …

WebMISSISSAUGA, ON, Nov. 15, 2021 /CNW/ - Nexviazyme™ (avalglucosidase alfa for injection) is now approved in Canada for the long-term treatment of patients older than 6 …

Category:  Health Go Health

Health Canada approves expanded indication for SOLIQUA®

WebLAVAL, QC, Dec. 18, 2020 /CNW Telbec/ - Sanofi Canada announced that Health Canada has approved expanded use of SOLIQUA ® . The once-daily injection, is now indicated …

Category:  Health Go Health

SARCLISA™ (isatuximab for injection) now available in Canada for

WebFirst and only anti-CD38 antibody in combination with pomalidomide and dexamethasone (pom-dex) to be approved in Canada 1,2; SARCLISA™ in combination …

Category:  Health Go Health